News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Senator of Economics Affairs Michael Westhagemann (left) and Ralf Sommer, CEO of the Hamburg Investment and Development Bank (right) hand over the notification of funding to Indivumed CEO Prof. Dr. Hartmut Juhl (Image: ©BVM)

Accelerated drug development and personalised treatments for cancer

Indivumed GmbH is a biotech company with international activities and representative offices in the US, Japan, Italy and Brasil. It cooperates with numerous international research ...

Read more …